161 related articles for article (PubMed ID: 34664818)
1. Investigating the Correlation between Growth Differentiation Factor 15 Serum Level and Its Gene Expression with Psoriasis and Its Severity.
Akbari H; Talaee R; Zaker SF; Nikoueinejad H
Iran J Allergy Asthma Immunol; 2021 Sep; 20(5):593-599. PubMed ID: 34664818
[TBL] [Abstract][Full Text] [Related]
2. Increased Serum Level of Growth Differentiation Factor 15 (GDF-15) is Associated with Coronary Artery Disease.
Wang X; Chen LL; Zhang Q
Cardiovasc Ther; 2016 Jun; 34(3):138-43. PubMed ID: 26996787
[TBL] [Abstract][Full Text] [Related]
3. Evaluating Serum Levels of IL-33, IL-36, IL-37 and Gene Expression of IL-37 in Patients with Psoriasis Vulgaris.
Sehat M; Talaei R; Dadgostar E; Nikoueinejad H; Akbari H
Iran J Allergy Asthma Immunol; 2018 Apr; 17(2):179-187. PubMed ID: 29757591
[TBL] [Abstract][Full Text] [Related]
4. Serum vascular endothelial growth factor, transforming growth factor β1, and nitric oxide levels in patients with psoriasis vulgaris: their correlation to disease severity.
Meki AR; Al-Shobaili H
J Clin Lab Anal; 2014 Nov; 28(6):496-501. PubMed ID: 24659464
[TBL] [Abstract][Full Text] [Related]
5. The association between serum levels of growth differentiation factor-15 and rheumatoid arthritis activity.
Esalatmanesh K; Fayyazi H; Esalatmanesh R; Khabbazi A
Int J Clin Pract; 2020 Sep; 74(9):e13564. PubMed ID: 32478946
[TBL] [Abstract][Full Text] [Related]
6. Growth Differentiation Factor 15 Predicts Chronic Liver Disease Severity.
Lee ES; Kim SH; Kim HJ; Kim KH; Lee BS; Ku BJ
Gut Liver; 2017 Mar; 11(2):276-282. PubMed ID: 27728964
[TBL] [Abstract][Full Text] [Related]
7. Novel inflammatory markers in psoriasis vulgaris: vaspin, vascular adhesion protein-1 (VAP-1), and YKL-40.
Ataseven A; Kesli R
G Ital Dermatol Venereol; 2016 Jun; 151(3):244-50. PubMed ID: 25279492
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor 15 increased in severe aplastic anemia patients.
Shao Y; Wang H; Liu C; Cao Q; Fu R; Wang H; Wang T; Qi W; Shao Z
Hematology; 2017 Oct; 22(9):548-553. PubMed ID: 28385068
[TBL] [Abstract][Full Text] [Related]
9. Serum concentrations of transforming growth factor beta 1 in patients with psoriasis vulgaris.
Nockowski P; Szepietowski JC; Ziarkiewicz M; Baran E
Acta Dermatovenerol Croat; 2004; 12(1):2-6. PubMed ID: 15072741
[TBL] [Abstract][Full Text] [Related]
10. [The value of growth differentiation factor-15 and extravascular lung water index in severity grading of acute respiratory distress syndrome patients and their prognosis prediction].
Shang M; Gao Y; Jia B; Wang B; Li S; Li-Tao X; Dong R; Sun Z; Lyu Y
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Oct; 32(10):1226-1230. PubMed ID: 33198869
[TBL] [Abstract][Full Text] [Related]
11. TGF-β1 Gene Polymorphism and Its Correlation with Serum Level of TGF-β1 in Psoriasis Vulgaris Among Iraqi People.
Ahmed BT; Saeed MY; Noori SH; Amin DM
Clin Cosmet Investig Dermatol; 2020; 13():889-896. PubMed ID: 33262631
[TBL] [Abstract][Full Text] [Related]
12. Serum Concentrations of Interferon Gamma (IFN-γ) in Patients with Psoriasis: Correlation with Clinical Type and Severity of the Disease.
Kurtovic NO; Halilovic EK
Med Arch; 2018 Dec; 72(6):410-413. PubMed ID: 30814771
[TBL] [Abstract][Full Text] [Related]
13. GDF-15: a novel serum marker for metastases in uveal melanoma patients.
Suesskind D; Schatz A; Schnichels S; Coupland SE; Lake SL; Wissinger B; Bartz-Schmidt KU; Henke-Fahle S
Graefes Arch Clin Exp Ophthalmol; 2012 Jun; 250(6):887-95. PubMed ID: 21881845
[TBL] [Abstract][Full Text] [Related]
14. Growth differentiation factor 15 as a useful biomarker for mitochondrial disorders.
Yatsuga S; Fujita Y; Ishii A; Fukumoto Y; Arahata H; Kakuma T; Kojima T; Ito M; Tanaka M; Saiki R; Koga Y
Ann Neurol; 2015 Nov; 78(5):814-23. PubMed ID: 26463265
[TBL] [Abstract][Full Text] [Related]
15. Association of serum growth differentiation factor 15 level with acute ischemic stroke in a Chinese population.
Dong X; Nao J
Int J Neurosci; 2019 Dec; 129(12):1247-1255. PubMed ID: 31446824
[No Abstract] [Full Text] [Related]
16. Serum GDF-15 level in Behçet's disease: relationships between disease activity and clinical parameters.
Sarıyıldız MA; Yazmalar L; Batmaz İ; Alpaycı M; Burkan YK; Sula B; Kaplan İ; Yıldız M; Akar ZA; Bozkurt M
Int J Dermatol; 2016 Nov; 55(11):1289-1294. PubMed ID: 27206990
[TBL] [Abstract][Full Text] [Related]
17. [Correlation between serum growth differentiation factor-15 and TIMI risk scores in patients with unstable angina pectoris].
Deng MY; Wu GP; Feng XX; Luo JB
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Jun; 31(7):1277-8. PubMed ID: 21764714
[TBL] [Abstract][Full Text] [Related]
18. Elevated serum levels of interleukin 21 are associated with disease severity in patients with psoriasis.
He Z; Jin L; Liu ZF; Hu L; Dang EL; Feng ZZ; Li QJ; Wang G
Br J Dermatol; 2012 Jul; 167(1):191-3. PubMed ID: 22356196
[TBL] [Abstract][Full Text] [Related]
19. GDF 15 as an anti-apoptotic, diagnostic and prognostic marker in oral squamous cell carcinoma.
Schiegnitz E; Kämmerer PW; Koch FP; Krüger M; Berres M; Al-Nawas B
Oral Oncol; 2012 Jul; 48(7):608-14. PubMed ID: 22341306
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of serum growth differentiation factor-15 levels in systemic sclerosis: association with disease severity.
Yanaba K; Asano Y; Tada Y; Sugaya M; Kadono T; Sato S
Mod Rheumatol; 2012 Sep; 22(5):668-75. PubMed ID: 22160844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
